This inventor holds 3 USPTO granted patents. Top assignee: University of California. Active years: 1997-2000.
Company Filing History:
Years Active: 1997-2000
Title: Innovations by Inventor Anthony Ho
Introduction
Anthony Ho is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors aimed at combating HIV. With a total of 3 patents to his name, his work has the potential to impact the lives of many individuals affected by this virus.
Latest Patents
One of Anthony Ho's latest patents is focused on retroviral vectors comprising an anti-HIV or other nucleic acid. This invention provides an infectious retrovirus that has a nucleic acid encoding an anti-HIV-type specific agent inserted between the 5' and 3' long terminal repeat sequences of the retrovirus. The nucleic acid is under the control of a pol III promoter. Additionally, host cells containing these retroviral vectors are also provided. The invention further includes methods for interfering with or preventing HIV viral replication in cells that are infected with HIV or likely to be infected.
Another significant patent by Ho is related to HIV-specific ribozymes. Similar to his previous invention, this patent also provides an infectious retrovirus with a nucleic acid encoding an anti-HIV-type specific agent inserted between the 5' and 3' long terminal repeat sequences. This invention aims to offer methods for interfering with or preventing HIV viral replication in infected cells.
Career Highlights
Anthony Ho is affiliated with the University of California, where he conducts his research and development work. His innovative approaches to tackling HIV have garnered attention in the scientific community, showcasing his commitment to advancing medical science.
Collaborations
Some of his notable coworkers include Flossie Wong-Staal and Mang Yu, who have collaborated with him on various projects related to HIV research.
Conclusion
In summary, Anthony Ho is a distinguished inventor whose work in developing retroviral vectors has the potential to make a significant impact in the fight against HIV. His contributions to biotechnology reflect his dedication to improving health outcomes for individuals affected by this virus.